ANAM SHARIQ: Open Payments
NPI 1144884891 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 71 payments from 13 companies in 2025. Trend: 2023 $107 · 2024 $209 · 2025 $1,495
Food & beverage: $1,479Education: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $480 |
| Alkermes, Inc. | 8 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $155 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: VRAYLAR, LYBALVI, CAPLYTA, REXULTI, Auvelity, AUSTEDO XR, INGREZZA, FANAPT.
Industry payments across FL — which companies pay providers there.
